Anti-GDNF Receptor alpha 1/GFRA1 antibody
4
(2 Reviews)
|
(23 Publications)
Rabbit Polyclonal GDNF Receptor alpha 1/GFRA1 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 23 publications.
View Alternative Names
GDNFRA, RETL1, TRNR1, GFRA1, GDNF family receptor alpha-1, GDNF receptor alpha-1, GDNFR-alpha-1, GFR-alpha-1, RET ligand 1, TGF-beta-related neurotrophic factor receptor 1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDNF Receptor alpha 1/GFRA1 antibody (AB8026)
Immunohistochemistry of human brain tissue staining GDNF Receptor alpha 1/GFRA1 using ab8026 at 2.5 μg/ml.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDNF Receptor alpha 1/GFRA1 antibody (AB8026)
Immunohistochemistry of human brain tissue staining GDNF Receptor alpha 1/GFRA1 using ab8026 at 1 μg/ml.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GDNF Receptor alpha 1/GFRA1 antibody (AB8026)
Immunocytochemistry of human brain tissue staining GDNF Receptor alpha 1/GFRA1 using ab8026 at 20 μg/ml.
- WB
Unknown
Western blot - Anti-GDNF Receptor alpha 1/GFRA1 antibody (AB8026)
Western blot analysis of GFR alpha 1/GFRA1 in crude membrane fractions of human brain (B), liver (L), kidney (K), and spleen (S), respectively, with ab8026 at 1/500 dilution.
All lanes:
Western blot - Anti-GDNF Receptor alpha 1/GFRA1 antibody (ab8026) at 1/500 dilution
Lane 1:
Crude membrane fractions of human brain
Lane 2:
Crude membrane fractions of liver
Lane 3:
Crude membrane fractions of kidney
Lane 4:
Crude membrane fractions of spleen
Predicted band size: 51 kDa
Observed band size: 50 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (23)
Recent publications for all applications. Explore the full list and refine your search
Molecular therapy. Nucleic acids 35:102342 PubMed40207021
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biomedicine 5:71 PubMed39681821
2024
Applications
Unspecified application
Species
Unspecified reactive species
The world journal of men's health 43:154-165 PubMed38606862
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:109024 PubMed38352225
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:883314 PubMed35676935
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 16:827628 PubMed35197829
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pediatrics 9:795678 PubMed35096711
2022
Applications
Unspecified application
Species
Unspecified reactive species
Andrology 10:340-353 PubMed34499811
2021
Applications
Unspecified application
Species
Unspecified reactive species
Antioxidants (Basel, Switzerland) 10: PubMed34068575
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biopreservation and biobanking 19:493-502 PubMed33926212
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com